financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
InMed Says Preclinical Data Show INM-901 'Significantly' Reduces Neuroinflammation; Shares Jump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
InMed Says Preclinical Data Show INM-901 'Significantly' Reduces Neuroinflammation; Shares Jump
Jun 24, 2025 5:17 AM

07:52 AM EDT, 06/24/2025 (MT Newswires) -- InMed Pharmaceuticals ( INM ) said Tuesday that new preclinical data show that INM-901 "significantly reduces" inflammation in ex vivo models of neuroinflammation.

The data demonstrate a statistically significant reduction of pro-inflammatory cytokines and levels of inflammasome marker NLRP3, supporting the potential of INM-901 as a therapeutic candidate for Alzheimer's disease, the company said.

InMed's shares climbed 96% in recent Tuesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Phillips 66 misses first-quarter profit estimates on weak margins
Phillips 66 misses first-quarter profit estimates on weak margins
Apr 26, 2024
(Reuters) -Refiner Phillips 66 missed quarterly profit estimates on Friday, hurt by a slump in refining margins following a decline in fuel prices. Refiner margins scaled back from the peaks achieved after Russia's invasion of Ukraine in 2022, amid a rise in global refining capacity. The company said its realized margins fell to $10.91 per barrel in the first quarter...
 Roper Technologies' Q1 Adjusted Earnings, Revenue Rise; Adjusted EPS Outlook Issued for Q2, Raised for 2024
Roper Technologies' Q1 Adjusted Earnings, Revenue Rise; Adjusted EPS Outlook Issued for Q2, Raised for 2024
Apr 26, 2024
07:32 AM EDT, 04/26/2024 (MT Newswires) -- Roper Technologies ( ROP ) reported Q1 adjusted earnings Friday of $4.41 per diluted share, up from $3.90 a year earlier. Analysts polled by Capital IQ expected $4.34. Revenue for the quarter ended March 31 was $1.68 billion, up from $1.47 billion a year earlier. Analysts surveyed by Capital IQ expected $1.65 billion....
 AutoNation's Q1 Adjusted Earnings Fall, Revenue Rises; Up to Additional $1 Billion Stock Buyback Approved
AutoNation's Q1 Adjusted Earnings Fall, Revenue Rises; Up to Additional $1 Billion Stock Buyback Approved
Apr 26, 2024
07:34 AM EDT, 04/26/2024 (MT Newswires) -- AutoNation ( AN ) reported Q1 adjusted earnings Friday of $4.49 per diluted share, down from $6.07 a year earlier. Analysts polled by Capital IQ expected $4.25. Revenue for the quarter ended March 31 was $6.49 billion, up from $6.40 billion a year earlier. Analysts surveyed by Capital IQ expected $6.51 billion. The...
 US Silica to be Acquired by Apollo in $1.85 Billion All-Cash Deal
US Silica to be Acquired by Apollo in $1.85 Billion All-Cash Deal
Apr 26, 2024
07:30 AM EDT, 04/26/2024 (MT Newswires) -- US Silica Holdings ( SLCA ) said Friday it has agreed to be acquired by funds managed by affiliates of Apollo Global Management ( APO ) in a deal valued at approximately $1.85 billion in cash. Under the terms of the deal, US Silica ( SLCA ) stockholders will receive $15.50 per share...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved